Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance
暂无分享,去创建一个
D. Holtzman | S. Paul | Hong Jiang | Jungsu Kim | M. Parsadanian | Joseph M. Castellano | Vi Pham | Jacob M Basak | Stephanie Mason | Maia Parsadanian
[1] D. Holtzman,et al. The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.
[2] Joachim Herz,et al. Apolipoprotein E receptors in the nervous system , 2009, Current opinion in lipidology.
[3] D. Russell,et al. Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan , 2009, Proceedings of the National Academy of Sciences.
[4] H. Mount,et al. Brainstem Concentrations of Cholesterol are not Influenced by Genetic Ablation of the Low-Density Lipoprotein Receptor , 2009, Neurochemical Research.
[5] Katie Hamm,et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. , 2008, The Journal of clinical investigation.
[6] P. S. St George-Hyslop,et al. Loss of γ-Secretase Function Impairs Endocytosis of Lipoprotein Particles and Membrane Cholesterol Homeostasis , 2008, The Journal of Neuroscience.
[7] D. Holtzman,et al. ApoE Promotes the Proteolytic Degradation of Aβ , 2008, Neuron.
[8] H. Soininen,et al. Genetic study evaluating LDLR polymorphisms and Alzheimer's disease , 2008, Neurobiology of Aging.
[9] D. Holtzman,et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.
[10] D. Holtzman,et al. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. , 2008, The Journal of clinical investigation.
[11] D. Bennett,et al. Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. , 2007, Human molecular genetics.
[12] Frank Z. Stanczyk,et al. Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice , 2007, The Journal of Neuroscience.
[13] R. Vassar,et al. Molecular Neurodegeneration BioMed Central Review The Alzheimer's disease β-secretase enzyme, BACE1 , 2007 .
[14] L. Muglia,et al. Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1 , 2007, Neuron.
[15] J. Buxbaum,et al. Elevated plasma cholesterol does not affect brain Aβ in mice lacking the low‐density lipoprotein receptor , 2007, Journal of neurochemistry.
[16] D. Holtzman,et al. Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] A. Soutar,et al. Mechanisms of Disease: genetic causes of familial hypercholesterolemia , 2007, Nature Clinical Practice Cardiovascular Medicine.
[18] D. Blacker,et al. The LDLR locus in alzheimer's disease: A family-based study and meta-analysis of case-control data , 2007, Neurobiology of Aging.
[19] D. Dickson,et al. Aβ40 Inhibits Amyloid Deposition In Vivo , 2007, The Journal of Neuroscience.
[20] D. Holtzman,et al. Apolipoprotein E and Low Density Lipoprotein Receptor-related Protein Facilitate Intraneuronal Aβ42 Accumulation in Amyloid Model Mice* , 2006, Journal of Biological Chemistry.
[21] K. Fukuchi,et al. Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice , 2006, Neurobiology of Aging.
[22] John Hardy,et al. A Hundred Years of Alzheimer's Disease Research , 2006, Neuron.
[23] Tony Wyss-Coray,et al. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.
[24] G. Bu,et al. Modulation of β-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family , 2006, Molecular Neurodegeneration.
[25] O. Combarros,et al. No association between low density lipoprotein receptor genetic variants and Alzheimer's disease risk , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[26] D. Holtzman,et al. Deletion of Abca1 Increases Aβ Deposition in the PDAPP Transgenic Mouse Model of Alzheimer Disease* , 2005, Journal of Biological Chemistry.
[27] M. Staufenbiel,et al. Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice* , 2005, Journal of Biological Chemistry.
[28] M. Hayden,et al. The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease* , 2005, Journal of Biological Chemistry.
[29] Rena Li,et al. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] D. Holtzman,et al. The Low Density Lipoprotein Receptor Regulates the Level of Central Nervous System Human and Murine Apolipoprotein E but Does Not Modify Amyloid Plaque Pathology in PDAPP Mice* , 2005, Journal of Biological Chemistry.
[31] E. Corder,et al. Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer’s disease , 2005, Journal of Medical Genetics.
[32] David A. Bennett,et al. Genetic association of low density lipoprotein receptor and Alzheimer's disease , 2005, Neurobiology of Aging.
[33] D. Holtzman,et al. Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] Bruce J Aronow,et al. ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition Evidence that ApoE Regulates Extracellular Aβ Metabolism In Vivo , 2004, Neuron.
[35] Joanna L. Jankowsky,et al. Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .
[36] J. Dietschy,et al. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. , 2003, Brain research. Developmental brain research.
[37] Heikki Tanila,et al. Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice , 2003, Neurobiology of Disease.
[38] D. Holtzman,et al. In Vivo Assessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-Life , 2003, The Journal of Neuroscience.
[39] M. Staufenbiel,et al. Extracellular amyloid formation and associated pathology in neural grafts , 2003, Nature Neuroscience.
[40] Sascha Weggen,et al. The cytoplasmic domain of the LDL receptor‐related protein regulates multiple steps in APP processing , 2002, The EMBO journal.
[41] Bruce J Aronow,et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] Sangram S. Sisodia,et al. γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in? , 2002, Nature Reviews Neuroscience.
[43] J. Thome,et al. Potential genetic markers of sporadic Alzheimer's dementia , 2001, Psychiatric genetics.
[44] F. Bian,et al. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. , 2001, The American journal of pathology.
[45] C. Haass,et al. Intramembrane proteolysis by presenilins , 2000, Nature Reviews Molecular Cell Biology.
[46] A. Fagan,et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model , 2000, Annals of neurology.
[47] A. Fagan,et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[48] B. Hyman,et al. Modulation of β-Amyloid Precursor Protein Processing by the Low Density Lipoprotein Receptor-related Protein (LRP) , 2000, The Journal of Biological Chemistry.
[49] S. Paul,et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[50] A Hofman,et al. Gender differences in the incidence of AD and vascular dementia , 1999, Neurology.
[51] D L Price,et al. A vector for expressing foreign genes in the brains and hearts of transgenic mice. , 1996, Genetic analysis : biomolecular engineering.
[52] J. B. Justice,et al. In vivo calibration of microdialysis probes for exogenous compounds. , 1992, Analytical chemistry.
[53] R. Hammer,et al. Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors. , 1990, Science.
[54] I. Filipović. Effect of inhibiting N-glycosylation on the stability and binding activity of the low density lipoprotein receptor. , 1989, The Journal of biological chemistry.
[55] E. Krul,et al. Heterogeneity of apolipoprotein E epitope expression on human lipoproteins: importance for apolipoprotein E function. , 1988, Journal of lipid research.
[56] R. Hammer,et al. Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice. , 1988, Science.
[57] M. Brown,et al. A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.
[58] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.
[59] D. Dickson,et al. Abeta40 inhibits amyloid deposition in vivo. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[60] M. Hofker,et al. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice , 2005, Clinical chemistry and laboratory medicine.
[61] D. Borchelt,et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. , 2004, Human molecular genetics.
[62] P. S. St George-Hyslop,et al. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? , 2002, Nature reviews. Neuroscience.
[63] H. Bock,et al. Lipoprotein receptors in the nervous system. , 2002, Annual review of biochemistry.
[64] R. Mahley,et al. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. , 1999, Journal of lipid research.
[65] S. Paul,et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. , 1997, Nature genetics.